SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The revenue for the December 2021 quarter is pegged at Rs. 3086.10 millions, about 21.99% up against Rs. 2529.70 millions recorded during the year-ago period.The Net Loss for the quarter ended December 2021 is Rs. -671.20 millions as compared to Net Loss of Rs. -686.70 millions of corresponding quarter ended December 2020Operating Profit saw a handsome growth to 180.90 millions from 16.60 millions in the quarter ended December 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202112 202012 % Var 202112 202012 % Var 202103 202003 % Var
Sales 3086.10 2529.70 21.99 8980.00 7255.10 23.77 9872.60 8900.60 10.92
Other Income 30.10 97.20 -69.03 228.20 344.20 -33.70 407.30 858.20 -52.54
PBIDT 180.90 16.60 989.76 520.80 -815.00 -163.90 -969.70 -901.20 7.60
Interest 792.20 492.00 61.02 1946.40 1547.80 25.75 2002.40 2201.70 -9.05
PBDT -611.30 -475.40 28.59 -1425.60 -3787.60 -62.36 -4396.90 -3102.90 41.70
Depreciation 428.60 427.20 0.33 1284.90 1317.70 -2.49 1840.80 1733.90 6.17
PBT -1039.90 -902.60 15.21 -2710.50 -5105.30 -46.91 -6237.70 -4836.80 28.96
TAX -368.70 -215.90 70.77 -915.40 -1655.40 -44.70 -2317.30 -1580.00 46.66
Deferred Tax -368.70 5.70 -6568.42 -915.40 -571.00 60.32 -949.30 -1108.90 -14.39
PAT -671.20 -686.70 -2.26 -1795.10 -3449.90 -47.97 -3920.40 -3256.80 20.38
Equity 554.10 553.90 0.04 554.10 553.90 0.04 553.90 553.70 0.04
PBIDTM(%) 5.86 0.66 793.29 5.80 -11.23 -151.63 -9.82 -10.13 -2.99

Wockhardt Share Price

1628.60 21.70 (1.35%)
11-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1872.40
Dr. Reddys Lab 1279.70
Cipla 1304.70
Zydus Lifesciences 956.65
Lupin 2245.65
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×